From November 13th to 17th, the 21st China High-tech Fair with the theme of "Building a Vigorous Bay Area Together, Opening Up and Innovating Together" was successfully held at the Shenzhen Convention and Exhibition Center. In the Nanshan district exhibition area, there are several blocks, including next-generation information technology, marine economy, high-end equipment manufacturing, biomedicine, green and low-carbon block, Hong Kong and Macau innovation and entrepreneurship teams, pilot teams, competition projects, etc.

Picture source: official website of High-tech Fair

Shenzhen TargetRx Inc. (hereinafter referred to as TargetRx) brings two leading products in this high-tech fair: the latest-generation Bcr-Abl inhibitor TGRX-678 for treating chronic myelogenous leukemia (CML) and the potent ALK inhibitor TGRX-326 for treating non-small cell lung cancer (NSCLC).

During the exhibition, Qiang Wang, Party Secretary of Nanshan District, Huawei Zhang, Secretary of the Discipline Inspection Commission of Nanshan District, Cong Lian, Deputy District Chief and other leaders of Nanshan District visited the Nanshan booth to inquire about the development status of TargetRx, and expressed their earnest concern about the progress of product development of TargetRx.

Innovation in Bay Area, Nanshan Goes First. TargetRx will continue to work hard in the field of new drug development, overcome the difficulties in the fight against cancer, save the lives of cancer patients, thus making greater contributions to the development of the biomedical industry in the Greater Bay Area.